Red or white wine consumption effect on atherosclerosis in healthy individuals (In Vino Veritas study)

Kód výsledku v IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F27661989%3A_____%2F17%3AN0000007" target="_blank" >RIV/27661989:_____/17:N0000007 - isvavai.cz</a>

Nalezeny alternativní kódy

RIV/61989592:15110/17:73582215 RIV/00098892:_____/17:N0000081 RIV/00023884:_____/12:00007510

Výsledek na webu

<a href="https://www.elis.sk/index.php?page=shop.product_details&flypage=flypage.tpl&product_id=5222&category_id=135&option=com_virtuemart&vmcchk=1&Itemid=1" target="_blank" >https://www.elis.sk/index.php?page=shop.product_details&flypage=flypage.tpl&product_id=5222&category_id=135&option=com_virtuemart&vmcchk=1&Itemid=1</a>

DOI - Digital Object Identifier

<a href="http://dx.doi.org/10.4149/BLL_2017_072" target="_blank" >10.4149/BLL_2017_072</a>

Jazyk výsledku

angličtina

Název v původním jazyce

Red or white wine consumption effect on atherosclerosis in healthy individuals (In Vino Veritas study)

Popis výsledku v původním jazyce

AIMS: Consumption of wine has a protective effect on cardiovascular diseases. Data from prospective, long-term, head-to-head comparisons of effects of different drinks on markers of atherosclerosis have been insufficient. METHODS AND RESULTS: In Vino Veritas (IVV) study is long-term, prospective, multi-centre, randomized trial comparing effects of red and white wine on atherosclerosis. 157 healthy subjects were randomized to white or red wine consumption for one year. We did not find increase in HDL-cholesterol in the whole group (1.66+/-0.58 vs 1.62+/-0.49, p=0.180) or difference between both groups (1.60+/-0.53 vs 1.64+/-0.46, p=0.634). At 12 months there was reduction of LDL-cholesterol in both groups, but with no difference between the groups (3.37+/-0.75 vs 3.60+/-1.10, p=0.134); there was no difference between the groups in total cholesterol, CRP, fasting blood glucose and liver function tests. Both groups had comparable differences from baseline in levels of parameters of oxidative stress. CONCLUSION: We did not find any clinically relevant differences in the lipid profile, CRP, fasting blood glucose and other markers of atherosclerosis, between long-term consumption of red and white wine. Moreover, we were unable to confirm the hypothesis that wine drinking is associated with an elevation of HDL (Tab. 7, Fig. 1, Ref. 30). Text in PDF www.elis.sk.

Název v anglickém jazyce

Red or white wine consumption effect on atherosclerosis in healthy individuals (In Vino Veritas study)

Popis výsledku anglicky

AIMS: Consumption of wine has a protective effect on cardiovascular diseases. Data from prospective, long-term, head-to-head comparisons of effects of different drinks on markers of atherosclerosis have been insufficient. METHODS AND RESULTS: In Vino Veritas (IVV) study is long-term, prospective, multi-centre, randomized trial comparing effects of red and white wine on atherosclerosis. 157 healthy subjects were randomized to white or red wine consumption for one year. We did not find increase in HDL-cholesterol in the whole group (1.66+/-0.58 vs 1.62+/-0.49, p=0.180) or difference between both groups (1.60+/-0.53 vs 1.64+/-0.46, p=0.634). At 12 months there was reduction of LDL-cholesterol in both groups, but with no difference between the groups (3.37+/-0.75 vs 3.60+/-1.10, p=0.134); there was no difference between the groups in total cholesterol, CRP, fasting blood glucose and liver function tests. Both groups had comparable differences from baseline in levels of parameters of oxidative stress. CONCLUSION: We did not find any clinically relevant differences in the lipid profile, CRP, fasting blood glucose and other markers of atherosclerosis, between long-term consumption of red and white wine. Moreover, we were unable to confirm the hypothesis that wine drinking is associated with an elevation of HDL (Tab. 7, Fig. 1, Ref. 30). Text in PDF www.elis.sk.

Druh

J_imp - Článek v periodiku v databázi Web of Science

CEP obor

—

OECD FORD obor

30200 - Clinical medicine

Projekt

—

Návaznosti

V - Vyzkumna aktivita podporovana z jinych verejnych zdroju

Rok uplatnění

2017

Kód důvěrnosti údajů

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Název periodika

Bratislava Medical Journal - Bratislavské lekárske listy

ISSN

0006-9248

e-ISSN

1336-0345

Svazek periodika

118

Číslo periodika v rámci svazku

5

Stát vydavatele periodika

SK - Slovenská republika

Počet stran výsledku

7

Strana od-do

292-298

Kód UT WoS článku

000403031700009

EID výsledku v databázi Scopus

2-s2.0-85019628427